Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 29INDUSTRY 22NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Squamous Cell Carcinoma of Head and Neck 3Recurrent Squamous Cell Lung Carcinoma 3Prostatic Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Non-small Cell Lung Cancer 1Solid Malignancies 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lung Cancer Metastatic 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Advanced Rare Tumours 1

Interventions

Cisplatin 3Taxes 2Psychiatric Rehabilitation 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Etoposide 2rubitecan 1pembrolizumab 1monalizumab 1marimastat 1etoposide phosphate 1durvalumab 1ceralasertib 1carfilzomib 1atezolizumab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Platinum Compounds 1PM 01183 1Nivolumab 1NK Cell Lectin-Like Receptor Subfamily C 1Mental Status and Dementia Tests 1Isotretinoin 1Irinotecan 1Ipilimumab 1Introns 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Small Cell Lung Carcinoma × durvalumab × Clear all
NCT06769126 2026-03-30

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

SWOG Cancer Research Network

Phase 2 Recruiting
900 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡